The Ensign Group, Inc. $ENSG Stock Position Trimmed by King Luther Capital Management Corp

King Luther Capital Management Corp cut its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 7.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 49,906 shares of the company’s stock after selling 4,288 shares during the quarter. King Luther Capital Management Corp’s holdings in The Ensign Group were worth $8,694,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in The Ensign Group by 9.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. lifted its position in The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after purchasing an additional 230 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in shares of The Ensign Group by 65.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock worth $83,000 after buying an additional 213 shares in the last quarter. Amundi raised its position in shares of The Ensign Group by 480,216.7% during the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. raised its position in shares of The Ensign Group by 26.1% during the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after buying an additional 421 shares in the last quarter. 96.12% of the stock is currently owned by institutional investors.

The Ensign Group Stock Down 0.3%

ENSG stock opened at $171.97 on Thursday. The Ensign Group, Inc. has a 52 week low of $134.79 and a 52 week high of $218.00. The company has a market capitalization of $10.05 billion, a price-to-earnings ratio of 28.01, a price-to-earnings-growth ratio of 1.69 and a beta of 0.73. The firm’s 50-day moving average is $189.95 and its two-hundred day moving average is $188.36. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Thursday, April 30th. The company reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same period in the previous year, the firm earned $1.52 EPS. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. On average, analysts forecast that The Ensign Group, Inc. will post 6.79 earnings per share for the current fiscal year.

The Ensign Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, April 30th. Investors of record on Tuesday, March 31st were issued a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Tuesday, March 31st. The Ensign Group’s payout ratio is presently 4.23%.

Insider Buying and Selling

In related news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $182.21, for a total value of $127,547.00. Following the sale, the director directly owned 22,052 shares in the company, valued at $4,018,094.92. The trade was a 3.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director owned 9,295 shares in the company, valued at $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,592 shares of company stock worth $512,364 over the last quarter. Insiders own 4.00% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Royal Bank Of Canada restated an “outperform” rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. Zacks Research downgraded shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a research report on Tuesday, April 21st. Finally, Truist Financial set a $215.00 price target on shares of The Ensign Group and gave the stock a “hold” rating in a research report on Friday, February 6th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $216.75.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.